GL1X · GenesisL1 explorer

MolNFT v1 · #104916 · protein

Catalytic domain of the antimicrobial peptidase lysostaphin from staphylococcus simulans crystallized in the presence of phosphate

4QP5: “Catalytic domain of the antimicrobial peptidase lysostaphin from staphylococcus simulans crystallized in the…”. X-ray diffraction, 2 ligands (ZN, PO4), 2 pockets (best druggability 0.60). MolNFT v1 #104916 on GenesisL1: 3D…

PDB
4QP5
Type
protein
Length
267 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysostaphin
EC
3.4.24.75
UniProt
P10547
Ligands
ZN, PO4
Pockets
2 · best druggability 0.60

Structure

x-ray diffraction · 2 distinct chains · 9% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysostaphin (EC 3.4.24.75)protein13410% helix, 41% strandP10547
BLysostaphin (EC 3.4.24.75)protein1339% helix, 44% strandP10547

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11520.600.8327PO4, GOL
21790.570.8130PO4, GOL

Interfaces

1 interface between chains.

  • A–B · 101 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 4QP5 · Catalytic domain of the antimicrobial peptidase lysostaphin from Staphylococcus simulans… · the same entry in another collection · chain A against A, TM-score 1.00
  • P10547 · AlphaFold monomer V2.0 prediction for lysostaphin (P10547) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.